
56 AMERICAN HOSPITAL & HEALTHCARE MANAGEMENT ISSUE 04 - 2024
with an increasing number of AI tools, making
the legacy approach unsustainable. All of this
can have a substantially negative impact an
organization’s operations and competitive edge.
When using a platform, on the other hand, the
“heavy lifting” is done once. Once a platform is
reviewed and securely integrated and adopted
by an organization, deploying individual AI
software can be as seamless as tuning on an
App, making a tool immediately available and
avoiding the repetitive, laborious, and costly
approach of legacy one at a time, standalone AI
tool adoption. This will enable the competitive
organization to lead in technology adoption.
Empowering the organization to
select the optimal AI application
AI tool performance can vary at different
hospital sites. Furthermore, for a given tool
performing a similar task, there are unique
aspects both from a diagnostic performance
and operational/workflow standpoint that
can make a given tool more or less desirable
depending on the specific hospital/organization’s
unique needs. One important direct benefit of
enabling effortless AI application deployment
through a platform is that it empowers the
organization and providers to try different
applications, providing them with first-hand
knowledge and exposure to functionality of
a given tool within that organization. Using
legacy approaches, trials (even if provided at
no cost by the vendor) are resource intensive
and costly to the organization, essentially
requiring the same degree resources that is
required for full adoption of a standalone
software discussed earlier. This disincentivizes
trials, especially when multiple applications
are being considered, and ultimately may
lead to procurement of a less-than-optimal
tool. By making application trials effortless
and less resource intensive, AI deployment
platforms enable seamless evaluation of
multiple applications, ultimately enabling
the organization to select the tool that is best
suited to the needs of the organization and its
providers.
Other benefits and a foundation for
AI of the future
Although a detailed discussion is beyond the
scope of this article, the ideal platform can
have many additional advantages that support
technology adoption and transformation of a
healthcare organization. Platforms support
interoperability and have the potential to
make AI applications more effective using
sophisticated image/date routing. They facilitate
management and integration of multiple
applications and can potentially support
multimodal applications that include both image
analysis and language or reporting tasks. Lastly,
with increasingly complex AI applications,
including development of biomarker tools that
perform tasks such as predicting a molecular
phenotype or treatment response, there will be a
requirement for more robust quality monitoring
tools. One can envisage platforms playing a
fundamental role in this essential requirement
of future advanced AI models. These are few
COVER STORY